Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR -mutated non-small cell lung cancer treated with erlotinib
2016 · Lung Cancer · 111 citations
https://doi.org/10.1016/j.lungcan.2016.08.001
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
279
Citations
6
h-index
5
i10-index
Steffen Filskov Sorensen is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Cancer Genomics and Diagnostics. The author has an h-index of 6, co-authored 8 publications.
Click to start Chat